FIBCLOT®▼ (Human fibrinogen)

Adverse events should be reported. Reporting forms and information can be found at

Adverse events should also be reported to Medical Information, Pharmalex, Tel: 01628 531171

Job Code: 22/11/082 – Date of preparation: January 2023

FIBCLOT®▼ Human fibrinogen 

Product Information
Click here to access the Patient Information Leaflet or Summary of Product Characteristics for FibCLOT®▼.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme.

By reporting side effects you can help provide more information on the safety of this medicine.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

FIBCLOT®▼ Human fibrinogen reconstitution video : suitable for healthcare professionals only.

If you are a registered healthcare professional, see the FibCLOT reconstitution video: